Dementia 

Background 

This guideline makes specific recommendations on Alzheimer's disease, dementia with Lewy bodies (DLB), frontotemporal dementia, vascular dementia and mixed dementias, as well as recommendations that apply to all types of dementia. The guideline was developed in collaboration with the Social Care Institute for Excellence (SCIE).

Dementia in Parkinson's disease shares a number of similarities with DLB. Although the evidence base for dementia in Parkinson's disease was not examined specifically in the context of this guideline, the recommendations for DLB may be useful when considering treatments for dementia in Parkinson's disease. NICE has also produced a clinical guideline on Parkinson's disease (available from NICE).

Guideline Product	Format
Quick reference guide	NICE
Understanding NICE guidance	NICE
Full guideline (including Appendices 1 to 7)
Appendices 8 to 12
Appendix 13
Appendices 14 & 16 to 20
Appendix 15
NICE-SCIE guideline	NICE

 
  Adobe Acrobat reader required

Related Information

NICE Technology Appraisals:

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (TA111)

Downloading files

All documents use PDF or HTML format. Click the file name to open the file in your web browser or right-click to save the file to your PC. Where you see the word NICE, clicking the file name will open a new window allowing you to download the file from the NICE website.

Printed versions

A printed version of the full guideline can be purchased from the RCPsych. Printed versions of some of the NICE products can be ordered here.